News Briefs
HIV-1 adult treatment guidelines are updated
"The Guidelines for the Use of Antiretro-viral Agents in HIV-1-Infected Adults and Adolescents" has been revised to include new recommendations for resistance testing, treatment interruption, and HBV/HIV co-infection. Tables have been revised to include up-to-date information about drug interactions and about the lopinavir/ritonavir 200/50 mg tablet formulation.
Changes to the document are summarized in the "What's New in the Document?" section, and all changes to the document are highlighted in yellow throughout the text.
The updated guidelines document is available in the adult guidelines section of the guidelines page on the www.AIDSinfo.nih.gov web site. The site also contains an option to order hard copies of the guidelines or request an electronic copy by e-mail.
CMS extends coverage for some O2 patients
The Centers for Medicare & Medicaid Services (CMS) will extend coverage for the home use of oxygen to Medicare beneficiaries enrolled in a CMS-approved clinical trial sponsored by the National Heart, Lung & Blood Institute.
Medicare currently provides coverage for home oxygen for beneficiaries with partial pressure measurements at or below 55 mmHg or oxygen saturation at or below 88%. If certain other diseases/conditions are present, coverage is provided for patients with an oxygen partial pressure of 56mmHg-60 mmHg or an oxygen saturation of 89%.
The trial will include Medicare beneficiaries with arterial oxygen partial measurements from 56 mmHg to 65 mmHg or whose oxygen saturation is at or above 89% who do not meet the current Medicare coverage requirements for home oxygen.
HIV-1 adult treatment guidelines are updated; CMS extends coverage for some O2 patientsSubscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.